Hussman Strategic Advisors, Inc. 10x Genomics, Inc. Transaction History

Hussman Strategic Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$40.86 - $62.98 $858,060 - $1.32 Million	21,000 New	21,000 $866,000
Q2 2022 Sep 12, 2022	SELL	$36.95 - $82.41 $114,545 - $255,471	-3,100 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$134.22 - $202.37 $416,082 - $627,347	3,100 New	3,100 $607,000
Q3 2020 Nov 02, 2020	SELL	$87.44 - $125.0 $1.8 Million - $2.58 Million	-20,600 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$58.39 - $89.31 $592,658 - $906,496	-10,150 Reduced 33.01%	20,600 $1.84 Million
Q1 2020 May 01, 2020	SELL	$51.57 - $106.62 $541,485 - $1.12 Million	-10,500 Reduced 25.45%	30,750 $1.92 Million
Q4 2019 Jan 31, 2020	SELL	$46.07 - $79.54 $472,217 - $815,285	-10,250 Reduced 19.9%	41,250 $3.15 Million
Q3 2019 Oct 31, 2019	BUY	$49.99 - $62.0 $2.57 Million - $3.19 Million	51,500 New	51,500 $2.6 Million

285

95.8M

162K

107K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.